Jitesh Joshi, M.D.
Hematology & Oncology Physician · Houston, TX
Jitesh Joshi, M.D. is a hematology & oncology physician with a practice address in Houston, Texas, and NPI 1679737969, issued on Jul 15, 2008. Check the license (Texas R2371, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Jitesh Joshi
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- R2371 TX
E-8600 AR
Self-reported in NPPES; status is on the state search - Practice location
- 18100 Houston Methodist Dr Ste 300, Houston, TX 77058
- Phone
- (832) 783-1190
- Enumerated
- Jul 15, 2008
- Record last updated
- Dec 14, 2025
- Fax
- (281) 333-0180
- Medicaid ID
- 373124201 TX
- Medicare enrollment
- Enrolled (PECOS I20170717003461); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 18100 Houston Methodist Dr Ste 300
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Natasha Hirani, DO, MPHMedical Oncology Physician1659715357
- Michelino Scarlata, M.D.Surgery Physician1508096413
Verify Jitesh Joshi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license R2371Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
27% more Medicare Part D claims than the average hematology & oncology physician in 2024
1,114 Medicare Part D claims for 185 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 26% of claims. 34 claims were for opioids.
Most prescribed
- Eliquis102 claims
- Tamoxifen Citrate81 claims
- Hydroxyurea80 claims
- Letrozole78 claims
- Prednisone65 claims
- Valacyclovir50 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $72.97
3 payments; by number, the most common kind was food and beverage; the largest payer was Array Biopharma Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Houston Methodist Specialty PhysiciansHouston, TX
- Tmh Physician Associates PLLCSugar Land, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Jitesh Joshi among 922 hematology & oncology physician records in Texas
Jitesh Joshi, M.D. is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2008, is newer than 53% of them.
- NPI issued2008 · 53% of these records are older, 41% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2007 · median 2004 among the 691 with a school on file
- Record last updated2025 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Houston → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Maria Scouros, MDHouston, TX 770551902922230
- Sita Bushan, MDHouston, TX 770541841635620
- Natalie Chen, MD, PHDHouston, TX 770541619474541
- Akiva DiamondHouston, TX 770541770902579
- Ahmed ElkhananyHouston, TX 770541245572510
- Sophia Lee, MDHouston, TX 770541588151401
- Leonido Luznik, M.D.Houston, TX 770541518902261
- Anaum Maqsood, M.D.Houston, TX 770541801203633
Common questions
What is Jitesh Joshi, M.D.'s NPI number?
Jitesh Joshi, M.D.'s National Provider Identifier (NPI) is 1679737969, issued on Jul 15, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Jitesh Joshi, M.D. located?
The NPPES record lists a practice address at 18100 Houston Methodist Dr Ste 300, Houston, TX, 77058. Phone: (832) 783-1190. Providers update this record themselves, so call before visiting.
How can I verify Jitesh Joshi, M.D.'s license?
NPPES lists Texas license number R2371, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jitesh Joshi, M.D. prescribe under Medicare Part D?
In 2024, Jitesh Joshi, M.D. had 1,114 Medicare Part D claims for 185 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.